RWPA
ARKG icon

Richard W. Paul & Associates’s ARK Genomic Revolution ETF ARKG Stock Holding History

Richard W. Paul & Associates’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18K Hold
28
– – ﹤0.01% 303
2026
Q1 		$740 Hold
28
– – ﹤0.01% 291
2025
Q4 		$811 Sell
28
-33
-54% -$991 ﹤0.01% 281
2025
Q3 		$1.69K Sell
61
-99
-62% -$2.5K ﹤0.01% 288
2025
Q2 		$3.9K Buy
160
+46
+40% +$1.01K ﹤0.01% 273
2025
Q1 		$2.37K Sell
114
-26
-19% -$653 ﹤0.01% 282
2024
Q4 		$3.3K Sell
140
-8
-5% -$197 ﹤0.01% 379
2024
Q3 		$3.79K Sell
148
-607
-80% -$15.5K ﹤0.01% 367
2024
Q2 		$17.7K Sell
755
-43
-5% -$1.08K 0.01% 261
2024
Q1 		$23K Sell
798
-100
-11% -$3.01K 0.01% 254
2023
Q4 		$29.5K Sell
898
-29
-3% -$789 0.01% 231
2023
Q3 		$25.8K Sell
927
-77
-8% -$2.52K 0.01% 229
2023
Q2 		$34.2K Buy
1,004
+192
+24% +$6.04K 0.01% 233
2023
Q1 		$24.4K Sell
812
-3
-0.4% -$93 0.01% 253
2022
Q4 		$23K Buy
+815
New +$25.9K 0.01% 256

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Richard W. Paul & Associates's ARKG Position: Q2 2026 in Review

Richard W. Paul & Associates held its ARK Genomic Revolution ETF (ARKG) position steady in Q2 2026 at 28 shares worth $1.18K. The position accounts for ﹤0.01% of the portfolio, ranked #303.

Richard W. Paul & Associates first reported a position in ARKG in Q4 2022 and has held it in 15 quarters since. The position peaked at $34.2K in Q2 2023. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Richard W. Paul & Associates held 28 shares of ARK Genomic Revolution ETF worth $1.18K as of Q2 2026.
  • Richard W. Paul & Associates left its ARK Genomic Revolution ETF share count unchanged in Q2 2026.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Richard W. Paul & Associates's portfolio in Q2 2026, its #303 holding.
  • Richard W. Paul & Associates first reported a position in ARK Genomic Revolution ETF in Q4 2022 and has held it in 15 quarters since.
  • Richard W. Paul & Associates's ARK Genomic Revolution ETF position peaked at $34.2K in Q2 2023.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Richard W. Paul & Associates's 13F filing for Q2 2026, filed 10 Aug 2026.